Investor Stock List
Ranked #2,468 of 8,699 institutional investors

Opaleye Management Inc.

Boston, MA

$935M
US stock portfolio at live prices · today −$5.3M (−0.56%)
Market closed. Prices as of Nov 20, 9:11 AM ET
Value at quarter end (Q3 2026)
$883M
Change from Q2 2026
−$221.2M (−20.03%)
Positions
49 · 9 new, 8 sold out
Filed
Nov 16, 2026

Not counted in the ranking: none$186M of holdings we could not match to a US listing are included at their reported quarter-end value.

Holdings

Q3 2026 13F, live prices
ETON 16.0%LQDA 12.8%IRON 8.91%HROW 7.23%TGTX 3.86%
StockSharesValue, live% of portfoliovs Q2 2026
ETON Eton Pharmaceuticals, Inc.2,440,000$150M16.0%Reduced −15%
LQDA Liquidia Corporation2,110,000$119M12.8%Reduced −14%
IRON Disc Medicine, Inc.1,095,000$83.3M8.91%Added +28%
HROW Harrow, Inc.2,105,000$67.6M7.23%Reduced −12%
TGTX TG Therapeutics, Inc.557,000$36.1M3.86%Added +4%
ACOG Alpha Cognition Inc.3,303,904$29.2M3.13%Added +14%
REPL Replimune Group, Inc.1,384,993$26.6M2.85%Unchanged
IMMX Immix Biopharma, Inc.2,825,000$19.9M2.13%Added +20%
VSTM Verastem, Inc.2,753,333$18.9M2.02%Added +53%
STOK Stoke Therapeutics, Inc.692,181$18.6M1.99%Reduced −1%
RZLT Rezolute, Inc.4,087,045$17.2M1.84%Reduced −35%
RVMD Revolution Medicines, Inc.100,000$15.9M1.70%Unchanged
RYTM Rhythm Pharmaceuticals, Inc.122,500$14.3M1.53%Unchanged
PTGX Protagonist Therapeutics, Inc.100,000$12.4M1.33%Unchanged
SMMT Summit Therapeutics Inc.1,051,901$11.1M1.19%New
QTTB Q32 Bio Inc.1,120,000$9.5M1.02%Added +20%
GLUE Monte Rosa Therapeutics, Inc.1,035,000$9.2M0.99%Added +39%
HRMY Harmony Biosciences Holdings, Inc.230,000$7.6M0.81%New
EWTX Edgewise Therapeutics, Inc.175,000$7.2M0.77%Reduced −65%
EDIT Editas Medicine, Inc.3,486,452$6.0M0.64%Reduced −10%
GRCE Grace Therapeutics, Inc.2,798,167$4.8M0.52%New
GOSS Gossamer Bio, Inc.426,989$4.8M0.51%New
ALMS Alumis Inc.1,001,900$4.3M0.46%Added +82%
TRVI Trevi Therapeutics, Inc.310,000$4.3M0.45%Unchanged
LYEL Lyell Immunopharma, Inc.291,353$4.0M0.42%Reduced −15%
FDMT 4D Molecular Therapeutics, Inc.334,437$3.6M0.38%Unchanged
INBX Inhibrx Biosciences, Inc.45,500$3.4M0.36%Added +124%
RLMD Relmada Therapeutics, Inc.1,000,000$3.1M0.33%Added +7%
IRD Opus Genetics, Inc.750,000$3.1M0.33%Reduced −33%
ANNX Annexon, Inc.875,000$3.0M0.32%Reduced −49%
OCUL Ocular Therapeutix, Inc.506,436$3.0M0.32%Reduced −16%
SNDX Syndax Pharmaceuticals, Inc.315,171$2.9M0.31%New
CDXS Codexis, Inc.2,590,000$2.7M0.29%Reduced −62%
VYGR Voyager Therapeutics, Inc.1,630,000$2.6M0.28%Added +38%
BLSM BlossomHill Therapeutics, Inc.175,000$2.5M0.27%New
CABA Cabaletta Bio, Inc.2,321,602$2.3M0.25%Reduced −40%
JBIO Jade Biosciences, Inc.140,463$2.1M0.23%Reduced −3%
RCKT Rocket Pharmaceuticals, Inc.1,000,000$2.1M0.23%Unchanged
ZNTL Zentalis Pharmaceuticals, Inc.1,412,656$1.9M0.21%Unchanged
FBIO Fortress Biotech, Inc.720,000$1.3M0.14%Reduced −19%
BBOT BridgeBio Oncology Therapeutics, Inc.630,000$1.2M0.13%Reduced −10%
MBX MBX Biosciences, Inc.20,000$1.1M0.11%Reduced −92%
ENTA Enanta Pharmaceuticals, Inc.125,000$998K0.11%Unchanged
OBX Obsidian Therapeutics, Inc.75,755$920K<0.1%New
KRRO Korro Bio, Inc.69,348$845K<0.1%New
BDSX Biodesix, Inc.87,000$722K<0.1%Reduced −52%
SNWV SANUWAVE Health, Inc.306,140$487K<0.1%Unchanged
DERM Journey Medical Corporation125,000$444K<0.1%Reduced −64%
SION Sionna Therapeutics, Inc.70,000$208K<0.1%New

Sold out in Q3 2026

StockShares held at Q2 2026Worth today
TRAX First Tracks Biotherapeutics, Inc.65,000$2.9M
NTLA Intellia Therapeutics, Inc.250,000$2.4M
COAG Hemab Therapeutics Holdings, Inc.47,652$1.9M
CGON CG Oncology, Inc.17,789$1.5M
KTTA Pasithea Therapeutics Corp.2,050,000$986K
PHAT Phathom Pharmaceuticals, Inc.185,589$943K
AVIR Atea Pharmaceuticals, Inc.235,000$924K
PTN Palatin Technologies, Inc.20,500$101K